Jill Ann Howe - Net Worth and Insider Trading

Jill Ann Howe Net Worth

The estimated net worth of Jill Ann Howe is at least $8,862 dollars as of 2024-11-05. Jill Ann Howe is the CFO of Lineage Cell Therapeutics Inc and owns about 10,500 shares of Lineage Cell Therapeutics Inc (LCTX) stock worth over $8,862. Details can be seen in Jill Ann Howe's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Jill Ann Howe has not made any transactions after 2024-08-16 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Jill Ann Howe

To

Jill Ann Howe Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Jill Ann Howe owns 2 companies in total, including Biora Therapeutics Inc (BIOR) , and Lineage Cell Therapeutics Inc (LCTX) .

Click here to see the complete history of Jill Ann Howe’s form 4 insider trades.

Insider Ownership Summary of Jill Ann Howe

Ticker Comapny Transaction Date Type of Owner
BIOR Biora Therapeutics Inc 2021-11-03 director
LCTX Lineage Cell Therapeutics Inc 2024-08-16 Chief Financial Officer

Jill Ann Howe Latest Holdings Summary

Jill Ann Howe currently owns a total of 1 stock. Jill Ann Howe owns 10,500 shares of Lineage Cell Therapeutics Inc (LCTX) as of August 16, 2024, with a value of $8,862.

Latest Holdings of Jill Ann Howe

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
LCTX Lineage Cell Therapeutics Inc 2024-08-16 10,500 0.84 8,862

Holding Weightings of Jill Ann Howe


Jill Ann Howe Form 4 Trading Tracker

According to the SEC Form 4 filings, Jill Ann Howe has made a total of 1 transactions in Lineage Cell Therapeutics Inc (LCTX) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Lineage Cell Therapeutics Inc is the acquisition of 10,500 shares on August 16, 2024, which cost Jill Ann Howe around $9,345.

Insider Trading History of Jill Ann Howe

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Jill Ann Howe Trading Performance

GuruFocus tracks the stock performance after each of Jill Ann Howe's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Jill Ann Howe is %. GuruFocus also compares Jill Ann Howe's trading performance to market benchmark return within the same time period. The performance of stocks bought by Jill Ann Howe within 3 months outperforms times out of transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Jill Ann Howe's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Jill Ann Howe

Average Return

No transaction record over 1 Year.

Outperforming Transactions

No transaction record over 1 Year.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 7.97 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 6.55 LIMIT LIMIT LIMIT LIMIT LIMIT

Jill Ann Howe Ownership Network

Ownership Network List of Jill Ann Howe

No Data

Ownership Network Relation of Jill Ann Howe

Insider Network Chart

Jill Ann Howe Owned Company Details

What does Biora Therapeutics Inc do?

Who are the key executives at Biora Therapeutics Inc?

Jill Ann Howe is the director of Biora Therapeutics Inc. Other key executives at Biora Therapeutics Inc include 10 percent owner Athyrium Opportunities Iii Co-invest 1 Lp , director & Chief Executive Officer Aditya P. Mohanty , and 10 percent owner Athyrium Capital Management, Lp .

Biora Therapeutics Inc (BIOR) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Biora Therapeutics Inc (BIOR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Biora Therapeutics Inc (BIOR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Biora Therapeutics Inc (BIOR)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Biora Therapeutics Inc Insider Transactions

No Available Data

Jill Ann Howe Mailing Address

Above is the net worth, insider trading, and ownership report for Jill Ann Howe. You might contact Jill Ann Howe via mailing address: C/o Dtx Pharma, Inc., 10655 Sorrento Valley Road, Suite 100, San Diego Ca 92121.